Tag Archives: pharmaceutical industry

Will Healthcare Reform Pay Off?

By George Koroneos | Published: August 20, 2009

Written by Jordan Melnick Members of Congress are in for a hard landing when they get back from recess in early September. After four weeks at home in their districts, the debate will heat up again as they resume the arduous process of crafting the biggest piece of President Obama’s domestic agenda. With the president demanding [...]

Posted in Regulatory | Also tagged Barack Obama, Health, Health care, Insurance, Medicare, Pharmaceutical Research and Manufacturers of America, White House | Leave a comment

Adverse Event Reports Go Digital Only

By George Koroneos | Published: August 20, 2009

Image via Wikipedia FDA, this morning, walked media through its proposed regulations requiring that pharma companies submit post-market adverse event reports through an electronic format. This is being done to help eliminate time and cost wasted on paper submissions. “This change will enhance FDA’s ability to rapidly identify new safety concerns and share safety information with [...]

Posted in Regulatory, Safety | Also tagged Adverse event, Center for Drug Evaluation and Research, Drug Evaluation and Research, FDA, U.S. Food and Drug Administration | 1 Comment

Pharma Accused of Keeping Good Generics Down

By Sarah Houlton | Published: July 15, 2009

Image via Wikipedia The European Commission has accused the pharmaceutical industry of delaying the entry of generic drugs to the market. As a result, it intends to step up its scrutiny of the sector under EU antitrust law. “We must have more competition and less red tape in pharmaceuticals,” claimed Competition Commissioner Neelie Kroes. “The inquiry [...]

Posted in Global, News | Also tagged business, Competition Commissioner Neelie Kroes, EU, European Commission, European Union, Generic drug, Neelie Kroes | 1 Comment

Moving On + Up

By Brittany Agro | Published: September 26, 2008

Promotions and hires for September 26, 2008: Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December GlaxoSmithKline named Ellen Strahlman chief medical officer Questcor Pharmaceuticals appointed Gary Sawka CFO Encorium appointed David Ginsberg president and CEO Wyeth named Daniel J. [...]

Posted in People | Also tagged announcements, business, communications, Encorium, executives, Ferring, Genesis, GlaxoSmithKline, Lilly, Merck, Merz, new hires, promotions, Questcor, Sanofi-Aventis, Wyeth, Zafgen, Zosano | Leave a comment